EA200300178A1 - Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие - Google Patents

Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие

Info

Publication number
EA200300178A1
EA200300178A1 EA200300178A EA200300178A EA200300178A1 EA 200300178 A1 EA200300178 A1 EA 200300178A1 EA 200300178 A EA200300178 A EA 200300178A EA 200300178 A EA200300178 A EA 200300178A EA 200300178 A1 EA200300178 A1 EA 200300178A1
Authority
EA
Eurasian Patent Office
Prior art keywords
heparin
mixtures
pharmaceutical compositions
reception
polysaccharides based
Prior art date
Application number
EA200300178A
Other languages
English (en)
Other versions
EA005995B1 (ru
Inventor
Жак Диаз
Кристель Пеке
Элизабет Перрэн
Кристиан Висков
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200300178(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200300178A1 publication Critical patent/EA200300178A1/ru
Publication of EA005995B1 publication Critical patent/EA005995B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Настоящее изобретение касается смесей полисахаридов на основе гепарина, способа их получения и фармацевтических композиций, их содержащих.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300178A 2000-07-21 2001-07-18 Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие EA005995B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2001/002332 WO2002008295A1 (fr) 2000-07-21 2001-07-18 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
EA200300178A1 true EA200300178A1 (ru) 2003-06-26
EA005995B1 EA005995B1 (ru) 2005-08-25

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300178A EA005995B1 (ru) 2000-07-21 2001-07-18 Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие

Country Status (36)

Country Link
EP (1) EP1307491B2 (ru)
JP (1) JP5279160B2 (ru)
KR (1) KR100853585B1 (ru)
CN (1) CN1230449C (ru)
AP (1) AP1703A (ru)
AR (1) AR029865A1 (ru)
AT (1) ATE470679T1 (ru)
AU (2) AU2001277602B2 (ru)
BR (1) BR0112612B1 (ru)
CA (1) CA2416673C (ru)
CL (1) CL2004001154A1 (ru)
CY (1) CY1110774T1 (ru)
DE (1) DE60142340D1 (ru)
DK (1) DK1307491T3 (ru)
DZ (1) DZ3411A1 (ru)
EA (1) EA005995B1 (ru)
EC (1) ECSP034442A (ru)
ES (1) ES2347134T5 (ru)
FR (1) FR2811992B1 (ru)
HK (1) HK1059273A1 (ru)
HR (1) HRP20030019A2 (ru)
HU (1) HUP0300755A3 (ru)
IL (2) IL153922A0 (ru)
MA (1) MA26928A1 (ru)
MX (1) MXPA03000579A (ru)
NO (1) NO20030296D0 (ru)
NZ (1) NZ524028A (ru)
OA (1) OA12340A (ru)
PL (1) PL202471B1 (ru)
PT (1) PT1307491E (ru)
SI (1) SI1307491T1 (ru)
TW (1) TWI307278B (ru)
UA (1) UA74836C2 (ru)
WO (1) WO2002008295A1 (ru)
YU (1) YU2903A (ru)
ZA (1) ZA200300898B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1375524B1 (en) * 2002-06-20 2007-03-07 CHEMI S.p.A. Process for the preparation of esters of heparin
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
EP2019843A2 (en) * 2006-05-25 2009-02-04 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
CN103209997B (zh) * 2010-09-14 2016-03-16 国立大学法人宫崎大学 高纯度肝素及其制备方法
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
ES2161615B1 (es) 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物

Also Published As

Publication number Publication date
NO20030296L (no) 2003-01-20
BR0112612B1 (pt) 2011-07-12
PT1307491E (pt) 2010-09-10
PL202471B1 (pl) 2009-06-30
CA2416673A1 (fr) 2002-01-31
ES2347134T3 (es) 2010-10-26
EP1307491A1 (fr) 2003-05-07
ECSP034442A (es) 2003-03-10
AP1703A (en) 2007-02-26
JP2004504451A (ja) 2004-02-12
IL153922A (en) 2010-05-17
PL365561A1 (en) 2005-01-10
KR100853585B1 (ko) 2008-08-21
AU2001277602B2 (en) 2007-07-19
MA26928A1 (fr) 2004-12-20
ATE470679T1 (de) 2010-06-15
AP2003002744A0 (en) 2003-03-31
BR0112612A (pt) 2003-07-29
HUP0300755A2 (hu) 2003-12-29
YU2903A (sh) 2006-03-03
NO20030296D0 (no) 2003-01-20
SI1307491T1 (sl) 2010-10-29
JP5279160B2 (ja) 2013-09-04
HRP20030019A2 (en) 2005-10-31
EP1307491B1 (fr) 2010-06-09
NZ524028A (en) 2004-12-24
OA12340A (fr) 2006-05-15
FR2811992A1 (fr) 2002-01-25
CN1230449C (zh) 2005-12-07
CY1110774T1 (el) 2015-06-10
DZ3411A1 (fr) 2002-01-31
ZA200300898B (en) 2004-04-30
AU7760201A (en) 2002-02-05
EA005995B1 (ru) 2005-08-25
WO2002008295A1 (fr) 2002-01-31
CN1447820A (zh) 2003-10-08
HK1059273A1 (en) 2004-06-25
HUP0300755A3 (en) 2004-03-01
KR20030040364A (ko) 2003-05-22
CA2416673C (fr) 2011-06-14
UA74836C2 (en) 2006-02-15
EP1307491B2 (fr) 2014-05-07
FR2811992B1 (fr) 2003-07-04
DK1307491T3 (da) 2010-10-11
TWI307278B (en) 2009-03-11
DE60142340D1 (de) 2010-07-22
AR029865A1 (es) 2003-07-16
CL2004001154A1 (es) 2005-05-27
IL153922A0 (en) 2003-07-31
MXPA03000579A (es) 2003-06-06
ES2347134T5 (es) 2014-06-24

Similar Documents

Publication Publication Date Title
EA200300178A1 (ru) Смеси полисахаридов на основе гепарина, их получение и фармацевтические композиции, их содержащие
EA200200940A1 (ru) Производные азетидина, способ их получения и содержащие их фармацевтические композиции
EA200300050A1 (ru) Гликопептидфосфонатные производные
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200100588A1 (ru) Пиперидины как модуляторы ccr5
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
EA200300453A1 (ru) Производные 3-ароилиндола и их применение в качестве агонистов рецепторов cb2
EA200400252A1 (ru) Стабильная полиморфная модификация флибансерина, способ её промышленного получения и её применение для получения лекарственных средств
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
EA200501250A1 (ru) Композиция, содержащая смесь активных начал, и способ ее получения
EA200001039A1 (ru) Кальцилитические соединения
EA200501341A1 (ru) Противобактериальные индолоноксазолидиноны, промежуточные соединения для их получения и содержащие их фармацевтические композиции
EA199800230A1 (ru) Тетрагидрохинолины в качестве антагонистов nmda (n-метил-d-аспарагиновой кислоты)
EA200101234A1 (ru) Новые производные аминотиазола, их получение и содержащие их фармацевтические композиции
EA200300579A1 (ru) Соединение лактама
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
EA200301224A1 (ru) Способ получения имипенема

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU